These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 7740508

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Determination of r DNA hirudin and A-human thrombin- hirudin complex in plasma samples: enzyme linked immunosorbent assays for hirudin and complex vs. chromogenic thrombin substrate assay.
    Berscheid G, Grötsch H, Neubauer H, Pünter J, Reindl J, Seipp P.
    Thromb Res; 1992 Apr 01; 66(1):33-42. PubMed ID: 1412181
    [Abstract] [Full Text] [Related]

  • 5. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
    Hafner G, Rupprecht HJ, Luz M, Terres W, Schindel F, Friesen HJ, Heinrichs H, Jessel A, Meyer J, Prellwitz W.
    Eur Heart J; 1996 Aug 01; 17(8):1207-15. PubMed ID: 8869862
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics study of recombinant hirudin in the plasma of rats using chromogenic substrate, ELISA, and radioisotope assays.
    Jiang SY, Jiao J, Zhang TT, Xu YP.
    PLoS One; 2013 Aug 01; 8(6):e64336. PubMed ID: 23785400
    [Abstract] [Full Text] [Related]

  • 7. Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assay.
    Pötzsch B, Hund S, Madlener K, Unkrig C, Müller-Berghaus G.
    Thromb Res; 1997 Jun 01; 86(5):373-83. PubMed ID: 9211628
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ecarin chromogenic assay--a new method for quantitative determination of direct thrombin inhibitors like hirudin.
    Lange U, Nowak G, Bucha E.
    Pathophysiol Haemost Thromb; 1997 Jun 01; 33(4):184-91. PubMed ID: 15583447
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Studies on the pharmacokinetics and pharmacodynamics of recombinant hirudin (rHV2-Lys 47) after intravenous and subcutaneous administration in dogs.
    Iyer L, Koza M, Iqbal O, Calabria R, Fareed J.
    Thromb Res; 1993 Feb 01; 69(3):259-69. PubMed ID: 8475476
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Radioimmunoassay for the detection of active-site specific thrombin inhibitors in biological fluids. II. Heparin affects the binding of hirudin to alpha-thrombin.
    Lackmann M, Geczy CL.
    Thromb Res; 1991 Sep 15; 63(6):609-16. PubMed ID: 1780805
    [Abstract] [Full Text] [Related]

  • 18. Determination of the specific activity of recombinant hirudin.
    Eric D.
    Thromb Res; 1990 Dec 15; 60(6):433-43. PubMed ID: 2082477
    [Abstract] [Full Text] [Related]

  • 19. Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group.
    Verstraete M, Nurmohamed M, Kienast J, Siebeck M, Silling-Engelhardt G, Büller H, Hoet B, Bichler J, Close P.
    J Am Coll Cardiol; 1993 Oct 15; 22(4):1080-8. PubMed ID: 8409044
    [Abstract] [Full Text] [Related]

  • 20. Assay of hirudin in plasma using a chromogenic thrombin substrate.
    Griessbach U, Stürzebecher J, Markwardt F.
    Thromb Res; 1985 Jan 15; 37(2):347-50. PubMed ID: 3975877
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.